← NDC auxiliary source history
FDA Establishment Identifier 118984002
Every current compounder row and every parsed outsourcing-response revision row carrying this exact FEI. Repeated physical rows and parser-specific revisions remain visible.
Establishment names in FDA source rows#
| Exact source name |
|---|
| Turbare Manufacturing |
Current compounder rows#
| Current source record | Source row | Product NDC | Package NDC | Active ingredient | Establishment | Period | Source date | Normalization | Row hash |
|---|---|---|---|---|---|---|---|---|---|
outsourcing:2026-1:129 | 129 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | 2026-1 | 2026-11-14 | valid | 3f6c215993bb… |
outsourcing:2026-1:1480 | 1480 | 83556-0510 | 83556-0510-2 | Vancomycin Hydrochloride | Turbare Manufacturing | 2026-1 | 2026-11-14 | valid | ddd7bf1298ed… |
outsourcing:2026-1:178 | 178 | 83556-0422 | 83556-0422-2 | Ceftazidime Anhydrous | Turbare Manufacturing | 2026-1 | 2026-11-14 | valid | 83ffa550763f… |
outsourcing:2025-2:130 | 130 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | 2025-2 | 2026-11-14 | valid | 0b972adee88b… |
outsourcing:2025-2:1532 | 1532 | 83556-0510 | 83556-0510-2 | Vancomycin Hydrochloride | Turbare Manufacturing | 2025-2 | 2026-11-14 | valid | 11de7ee16280… |
outsourcing:2025-2:176 | 176 | 83556-0422 | 83556-0422-2 | Ceftazidime Anhydrous | Turbare Manufacturing | 2025-2 | 2026-11-14 | valid | b27315266aa8… |
outsourcing:2025-1:121 | 121 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | 2025-1 | 2026-11-14 | valid | fb63e352f931… |
outsourcing:2025-1:1272 | 1272 | 83556-0201 | 83556-0201-2 | Semaglutide | Turbare Manufacturing | 2025-1 | 2026-11-14 | valid | 3b81e735937b… |
outsourcing:2025-1:1273 | 1273 | 83556-0205 | 83556-0205-5 | Semaglutide | Turbare Manufacturing | 2025-1 | 2026-11-14 | valid | ce7a75720b58… |
outsourcing:2025-1:1614 | 1614 | 83556-0510 | 83556-0510-2 | Vancomycin Hydrochloride | Turbare Manufacturing | 2025-1 | 2026-11-14 | valid | 454a435520a4… |
outsourcing:2025-1:168 | 168 | 83556-0422 | 83556-0422-2 | Ceftazidime Anhydrous | Turbare Manufacturing | 2025-1 | 2026-11-14 | valid | eb58c3e2052a… |
outsourcing:2024-2:126 | 126 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | 2024-2 | 2026-11-14 | valid | ab3c9508e6c4… |
Parsed outsourcing-response revision rows#
These are physical source-row memberships from every distinct parsed response revision, not deduplicated current records.
| Parsed revision | Source JSON | Period | Source date | Product NDC | Package NDC | Active ingredient | Establishment | Parser | Row hash |
|---|---|---|---|---|---|---|---|---|---|
ce3ced9163b6… | 129 | 2026-1 | 2026-11-14 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 3f6c215993bb… |
ce3ced9163b6… | 178 | 2026-1 | 2026-11-14 | 83556-0422 | 83556-0422-2 | Ceftazidime Anhydrous | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 83ffa550763f… |
ce3ced9163b6… | 1480 | 2026-1 | 2026-11-14 | 83556-0510 | 83556-0510-2 | Vancomycin Hydrochloride | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | ddd7bf1298ed… |
a0f355c22ab8… | 130 | 2025-2 | 2026-11-14 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 0b972adee88b… |
a0f355c22ab8… | 176 | 2025-2 | 2026-11-14 | 83556-0422 | 83556-0422-2 | Ceftazidime Anhydrous | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | b27315266aa8… |
a0f355c22ab8… | 1532 | 2025-2 | 2026-11-14 | 83556-0510 | 83556-0510-2 | Vancomycin Hydrochloride | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 11de7ee16280… |
e84b71a3d2be… | 121 | 2025-1 | 2026-11-14 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | fb63e352f931… |
e84b71a3d2be… | 168 | 2025-1 | 2026-11-14 | 83556-0422 | 83556-0422-2 | Ceftazidime Anhydrous | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | eb58c3e2052a… |
e84b71a3d2be… | 1272 | 2025-1 | 2026-11-14 | 83556-0201 | 83556-0201-2 | Semaglutide | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 3b81e735937b… |
e84b71a3d2be… | 1273 | 2025-1 | 2026-11-14 | 83556-0205 | 83556-0205-5 | Semaglutide | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | ce7a75720b58… |
e84b71a3d2be… | 1614 | 2025-1 | 2026-11-14 | 83556-0510 | 83556-0510-2 | Vancomycin Hydrochloride | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 454a435520a4… |
b9251e57ff7d… | 126 | 2024-2 | 2026-11-14 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | ab3c9508e6c4… |
4e9b3bad06ad… | 129 | 2026-1 | 2026-11-12 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 3f6c215993bb… |
4e9b3bad06ad… | 178 | 2026-1 | 2026-11-12 | 83556-0422 | 83556-0422-2 | Ceftazidime Anhydrous | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 83ffa550763f… |
4e9b3bad06ad… | 1480 | 2026-1 | 2026-11-12 | 83556-0510 | 83556-0510-2 | Vancomycin Hydrochloride | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | ddd7bf1298ed… |
a1adc6aa8212… | 130 | 2025-2 | 2026-11-12 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 0b972adee88b… |
a1adc6aa8212… | 176 | 2025-2 | 2026-11-12 | 83556-0422 | 83556-0422-2 | Ceftazidime Anhydrous | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | b27315266aa8… |
a1adc6aa8212… | 1532 | 2025-2 | 2026-11-12 | 83556-0510 | 83556-0510-2 | Vancomycin Hydrochloride | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 11de7ee16280… |
f940ee0e2d4a… | 121 | 2025-1 | 2026-11-12 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | fb63e352f931… |
f940ee0e2d4a… | 168 | 2025-1 | 2026-11-12 | 83556-0422 | 83556-0422-2 | Ceftazidime Anhydrous | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | eb58c3e2052a… |
f940ee0e2d4a… | 1272 | 2025-1 | 2026-11-12 | 83556-0201 | 83556-0201-2 | Semaglutide | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 3b81e735937b… |
f940ee0e2d4a… | 1273 | 2025-1 | 2026-11-12 | 83556-0205 | 83556-0205-5 | Semaglutide | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | ce7a75720b58… |
f940ee0e2d4a… | 1614 | 2025-1 | 2026-11-12 | 83556-0510 | 83556-0510-2 | Vancomycin Hydrochloride | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 454a435520a4… |
170a2039d539… | 126 | 2024-2 | 2026-11-12 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | ab3c9508e6c4… |
49589bf5af4b… | 129 | 2026-1 | 2026-11-10 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 3f6c215993bb… |
49589bf5af4b… | 178 | 2026-1 | 2026-11-10 | 83556-0422 | 83556-0422-2 | Ceftazidime Anhydrous | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 83ffa550763f… |
49589bf5af4b… | 1480 | 2026-1 | 2026-11-10 | 83556-0510 | 83556-0510-2 | Vancomycin Hydrochloride | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | ddd7bf1298ed… |
19e51297a9cc… | 130 | 2025-2 | 2026-11-10 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 0b972adee88b… |
19e51297a9cc… | 176 | 2025-2 | 2026-11-10 | 83556-0422 | 83556-0422-2 | Ceftazidime Anhydrous | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | b27315266aa8… |
19e51297a9cc… | 1532 | 2025-2 | 2026-11-10 | 83556-0510 | 83556-0510-2 | Vancomycin Hydrochloride | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 11de7ee16280… |
c7f823a6e093… | 121 | 2025-1 | 2026-11-10 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | fb63e352f931… |
c7f823a6e093… | 168 | 2025-1 | 2026-11-10 | 83556-0422 | 83556-0422-2 | Ceftazidime Anhydrous | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | eb58c3e2052a… |
c7f823a6e093… | 1272 | 2025-1 | 2026-11-10 | 83556-0201 | 83556-0201-2 | Semaglutide | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 3b81e735937b… |
c7f823a6e093… | 1273 | 2025-1 | 2026-11-10 | 83556-0205 | 83556-0205-5 | Semaglutide | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | ce7a75720b58… |
c7f823a6e093… | 1614 | 2025-1 | 2026-11-10 | 83556-0510 | 83556-0510-2 | Vancomycin Hydrochloride | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 454a435520a4… |
04d567e6c6e6… | 126 | 2024-2 | 2026-11-10 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | ab3c9508e6c4… |
bc1c0749bbc0… | 129 | 2026-1 | 2026-11-08 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 3f6c215993bb… |
bc1c0749bbc0… | 178 | 2026-1 | 2026-11-08 | 83556-0422 | 83556-0422-2 | Ceftazidime Anhydrous | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 83ffa550763f… |
bc1c0749bbc0… | 1480 | 2026-1 | 2026-11-08 | 83556-0510 | 83556-0510-2 | Vancomycin Hydrochloride | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | ddd7bf1298ed… |
86d6aba062ce… | 130 | 2025-2 | 2026-11-08 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 0b972adee88b… |
86d6aba062ce… | 176 | 2025-2 | 2026-11-08 | 83556-0422 | 83556-0422-2 | Ceftazidime Anhydrous | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | b27315266aa8… |
86d6aba062ce… | 1532 | 2025-2 | 2026-11-08 | 83556-0510 | 83556-0510-2 | Vancomycin Hydrochloride | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 11de7ee16280… |
973820f7e8bf… | 121 | 2025-1 | 2026-11-08 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | fb63e352f931… |
973820f7e8bf… | 168 | 2025-1 | 2026-11-08 | 83556-0422 | 83556-0422-2 | Ceftazidime Anhydrous | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | eb58c3e2052a… |
973820f7e8bf… | 1272 | 2025-1 | 2026-11-08 | 83556-0201 | 83556-0201-2 | Semaglutide | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 3b81e735937b… |
973820f7e8bf… | 1273 | 2025-1 | 2026-11-08 | 83556-0205 | 83556-0205-5 | Semaglutide | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | ce7a75720b58… |
973820f7e8bf… | 1614 | 2025-1 | 2026-11-08 | 83556-0510 | 83556-0510-2 | Vancomycin Hydrochloride | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 454a435520a4… |
e438bdb75db0… | 126 | 2024-2 | 2026-11-08 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | ab3c9508e6c4… |
9bc3acee5a5a… | 129 | 2026-1 | 2026-11-06 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 3f6c215993bb… |
9bc3acee5a5a… | 178 | 2026-1 | 2026-11-06 | 83556-0422 | 83556-0422-2 | Ceftazidime Anhydrous | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 83ffa550763f… |
9bc3acee5a5a… | 1480 | 2026-1 | 2026-11-06 | 83556-0510 | 83556-0510-2 | Vancomycin Hydrochloride | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | ddd7bf1298ed… |
109efb26b9e5… | 130 | 2025-2 | 2026-11-06 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 0b972adee88b… |
109efb26b9e5… | 176 | 2025-2 | 2026-11-06 | 83556-0422 | 83556-0422-2 | Ceftazidime Anhydrous | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | b27315266aa8… |
109efb26b9e5… | 1532 | 2025-2 | 2026-11-06 | 83556-0510 | 83556-0510-2 | Vancomycin Hydrochloride | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 11de7ee16280… |
9895610cdb99… | 121 | 2025-1 | 2026-11-06 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | fb63e352f931… |
9895610cdb99… | 168 | 2025-1 | 2026-11-06 | 83556-0422 | 83556-0422-2 | Ceftazidime Anhydrous | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | eb58c3e2052a… |
9895610cdb99… | 1272 | 2025-1 | 2026-11-06 | 83556-0201 | 83556-0201-2 | Semaglutide | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 3b81e735937b… |
9895610cdb99… | 1273 | 2025-1 | 2026-11-06 | 83556-0205 | 83556-0205-5 | Semaglutide | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | ce7a75720b58… |
9895610cdb99… | 1614 | 2025-1 | 2026-11-06 | 83556-0510 | 83556-0510-2 | Vancomycin Hydrochloride | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 454a435520a4… |
a336954e10c5… | 126 | 2024-2 | 2026-11-06 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | ab3c9508e6c4… |
9ec09a220edb… | 129 | 2026-1 | 2026-11-04 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 3f6c215993bb… |
9ec09a220edb… | 178 | 2026-1 | 2026-11-04 | 83556-0422 | 83556-0422-2 | Ceftazidime Anhydrous | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 83ffa550763f… |
9ec09a220edb… | 1480 | 2026-1 | 2026-11-04 | 83556-0510 | 83556-0510-2 | Vancomycin Hydrochloride | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | ddd7bf1298ed… |
f89fec0b1fa9… | 130 | 2025-2 | 2026-11-04 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 0b972adee88b… |
f89fec0b1fa9… | 176 | 2025-2 | 2026-11-04 | 83556-0422 | 83556-0422-2 | Ceftazidime Anhydrous | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | b27315266aa8… |
f89fec0b1fa9… | 1532 | 2025-2 | 2026-11-04 | 83556-0510 | 83556-0510-2 | Vancomycin Hydrochloride | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 11de7ee16280… |
1e44eef63b73… | 121 | 2025-1 | 2026-11-04 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | fb63e352f931… |
1e44eef63b73… | 168 | 2025-1 | 2026-11-04 | 83556-0422 | 83556-0422-2 | Ceftazidime Anhydrous | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | eb58c3e2052a… |
1e44eef63b73… | 1272 | 2025-1 | 2026-11-04 | 83556-0201 | 83556-0201-2 | Semaglutide | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 3b81e735937b… |
1e44eef63b73… | 1273 | 2025-1 | 2026-11-04 | 83556-0205 | 83556-0205-5 | Semaglutide | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | ce7a75720b58… |
1e44eef63b73… | 1614 | 2025-1 | 2026-11-04 | 83556-0510 | 83556-0510-2 | Vancomycin Hydrochloride | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 454a435520a4… |
0a51abfe1a47… | 126 | 2024-2 | 2026-11-04 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | ab3c9508e6c4… |
7e8773e03a6f… | 129 | 2026-1 | 2026-11-02 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 3f6c215993bb… |
7e8773e03a6f… | 178 | 2026-1 | 2026-11-02 | 83556-0422 | 83556-0422-2 | Ceftazidime Anhydrous | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 83ffa550763f… |
7e8773e03a6f… | 1480 | 2026-1 | 2026-11-02 | 83556-0510 | 83556-0510-2 | Vancomycin Hydrochloride | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | ddd7bf1298ed… |
11d34a39ee52… | 130 | 2025-2 | 2026-11-02 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 0b972adee88b… |
11d34a39ee52… | 176 | 2025-2 | 2026-11-02 | 83556-0422 | 83556-0422-2 | Ceftazidime Anhydrous | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | b27315266aa8… |
11d34a39ee52… | 1532 | 2025-2 | 2026-11-02 | 83556-0510 | 83556-0510-2 | Vancomycin Hydrochloride | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 11de7ee16280… |
3d45279275a8… | 121 | 2025-1 | 2026-11-02 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | fb63e352f931… |
3d45279275a8… | 168 | 2025-1 | 2026-11-02 | 83556-0422 | 83556-0422-2 | Ceftazidime Anhydrous | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | eb58c3e2052a… |
3d45279275a8… | 1272 | 2025-1 | 2026-11-02 | 83556-0201 | 83556-0201-2 | Semaglutide | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 3b81e735937b… |
3d45279275a8… | 1273 | 2025-1 | 2026-11-02 | 83556-0205 | 83556-0205-5 | Semaglutide | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | ce7a75720b58… |
3d45279275a8… | 1614 | 2025-1 | 2026-11-02 | 83556-0510 | 83556-0510-2 | Vancomycin Hydrochloride | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 454a435520a4… |
163c800484e6… | 126 | 2024-2 | 2026-11-02 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | ab3c9508e6c4… |
a5f257d65e69… | 129 | 2026-1 | 2026-10-31 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 3f6c215993bb… |
a5f257d65e69… | 178 | 2026-1 | 2026-10-31 | 83556-0422 | 83556-0422-2 | Ceftazidime Anhydrous | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 83ffa550763f… |
a5f257d65e69… | 1480 | 2026-1 | 2026-10-31 | 83556-0510 | 83556-0510-2 | Vancomycin Hydrochloride | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | ddd7bf1298ed… |
1e91139cc472… | 130 | 2025-2 | 2026-10-31 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 0b972adee88b… |
1e91139cc472… | 176 | 2025-2 | 2026-10-31 | 83556-0422 | 83556-0422-2 | Ceftazidime Anhydrous | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | b27315266aa8… |
1e91139cc472… | 1532 | 2025-2 | 2026-10-31 | 83556-0510 | 83556-0510-2 | Vancomycin Hydrochloride | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 11de7ee16280… |
b69cf77fa5ab… | 121 | 2025-1 | 2026-10-31 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | fb63e352f931… |
b69cf77fa5ab… | 168 | 2025-1 | 2026-10-31 | 83556-0422 | 83556-0422-2 | Ceftazidime Anhydrous | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | eb58c3e2052a… |
b69cf77fa5ab… | 1272 | 2025-1 | 2026-10-31 | 83556-0201 | 83556-0201-2 | Semaglutide | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 3b81e735937b… |
b69cf77fa5ab… | 1273 | 2025-1 | 2026-10-31 | 83556-0205 | 83556-0205-5 | Semaglutide | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | ce7a75720b58… |
b69cf77fa5ab… | 1614 | 2025-1 | 2026-10-31 | 83556-0510 | 83556-0510-2 | Vancomycin Hydrochloride | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 454a435520a4… |
66dfa2d230d8… | 126 | 2024-2 | 2026-10-31 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | ab3c9508e6c4… |
ead1c01bde9c… | 129 | 2026-1 | 2026-10-30 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 3f6c215993bb… |
ead1c01bde9c… | 178 | 2026-1 | 2026-10-30 | 83556-0422 | 83556-0422-2 | Ceftazidime Anhydrous | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 83ffa550763f… |
ead1c01bde9c… | 1480 | 2026-1 | 2026-10-30 | 83556-0510 | 83556-0510-2 | Vancomycin Hydrochloride | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | ddd7bf1298ed… |
dbc8d1701154… | 130 | 2025-2 | 2026-10-30 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 0b972adee88b… |